Monoclonal Antibodies Segment is the largest segment driving the growth of Antibodies Market.

Antibodies Market 

 


The global Antibodies Market is estimated to be valued at US$ 224,083.5 Mn or Bn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:


Antibodies are Y-shaped proteins produced by B cells of the immune system in response to perceived foreign invaders such as bacteria and viruses. They help identify and eliminate foreign objects like bacteria and viruses. The antibodies have wide applications in research, diagnostics and therapeutics.


Market key trends:


One of the key trends in the antibodies market is the growing R&D in antibodies for application in cancer therapeutics. Research in monoclonal antibodies has shown potential in targeted drug delivery for cancer treatment. Advances in antibody engineering technologies like humanization, affinity maturation, and conjugation are enabling development of more potent and safer antibodies to treat various cancers. Antibody drug conjugates are among the promising areas of cancer research that link cytotoxic agents to antibodies that bind to tumor cell antigens.



Market key trends:


The antibodies market has been witnessing high demand formonoclonal antibodies owing to their rising application areas in therapeutics. Monoclonal antibodies have emerged as a major category of biologics in treating various chronic and life-threatening diseases such as cancer. Additionally, increasing prevalence of chronic diseases and success of antibody-based drugs in treating chronic illnesses are some of the major factors augmenting the growth of this market.


SWOT Analysis


Strength: Presence of large pool of key players with strong financial capabilities for carrying out extensive R&D.
Weakness: High development cost of antibody drugs and long duration of clinical trials.
Opportunity: Rising healthcare expenditure in emerging economies and untapped growth potential in developing markets.
Threats: Patent expiries of blockbuster drugs and biosimilars entering the market.


Key Takeaways


The Global Antibodies Market Size is expected to witness high growth, exhibiting CAGR of 12.% over the forecast period, due to increasing prevalence of chronic diseases.

Regional analysis: North America dominated the global antibodies market in 2023 and is expected to maintain its leading position during the forecast period. This can be attributed to growing demand for monoclonal antibody therapeutics and strong presence of key market players in the region. Asia Pacific is expected to exhibit fastest growth over the forecast period supported by rising healthcare investments, increasing disposable income and growing awareness.

Key players: Novartis AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi, Eli Lilly and Co., Iovance Biotherapeutics, Inc., Ultragenyx Pharmaceutical Inc., and Kyowa Kirin Co., Ltd.


Read More - https://www.insightprobing.com/antibodies-market-share-size-demand-analysis-growth-and-trends-forecast/

Comments

Post a Comment

Popular posts from this blog

Riding the Wave: Navigating Dynamics in the Windsurf Foil Board Market

Image
   Windsurf Foil Board Market In the exhilarating world of water sports, the Windsurf Foil Board Market emerges as a key player, offering enthusiasts innovative equipment to enhance their riding experience. As this niche market continues to gain traction among windsurfing aficionados worldwide, it undergoes significant shifts influenced by various drivers, challenges, and geographical nuances. The Windsurf Foil Board Market size was valued at  US$ 167.4 Mn in 2024  and is expected to reach  US$ 268.6 Mn by 2031 , growing at a compound annual growth rate  (CAGR) of 7% from 2024 to 2031 Key Takeaways A prominent trend in the Windsurf Foil Board Market Demand is the increasing adoption of foil technology. Foil boards, equipped with hydrofoils beneath the waterline, enable riders to glide effortlessly above the water's surface, providing a thrilling and dynamic experience. This technological innovation has revolutionized the windsurfing landscape, attrac...
Read more

Idiopathic Hypersomnia Treatment Market is Anticipated to Witness High Growth Owing to Increasing Prevalence of Idiopathic Hypersomnia

Image
  Idiopathic Hypersomnia Treatment Market Idiopathic hypersomnia is a neurological sleep disorder characterized by excessive daytime sleepiness and long periods of sleep that does not improve even after long sleep. The treatment of idiopathic hypersomnia is done through medication and behavioral therapies. Medications like psychostimulants, serotonin modulators, wakefulness promoting agents are used to treat the condition and increase wakefulness. The increasing prevalence of idiopathic hypersomnia due to genetic and environmental factors is expected to drive the growth of the idiopathic hypersomnia treatment market. The Global Idiopathic Hypersomnia Treatment Market is estimated to be valued at US$ 389.86 Mn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2030. Key Takeaways Key players operating in the Idiopathic Hypersomnia Treatment Market are Esaote SPA, Epica Animal Health, IDEXX Laboratories, Carestream Health, IMV Imaging, Fujifilm Hold...
Read more

Navigating Opportunities In The Niemann-Pick Disease Drug Type C Treatment Market

Image
  Niemann-Pick Disease Drug Type C Treatment Market Key Takeaways The Niemann-Pick Disease Drug Type C Treatment Market is witnessing significant growth, driven by advancements in medical research and a deeper understanding of the disease pathology. Niemann-Pick Disease Type C (NPC) is a rare genetic disorder characterized by the accumulation of cholesterol and other lipids within cells, leading to progressive neurological and visceral symptoms. With an increasing focus on rare diseases and orphan drug development, the market for NPC treatment is expanding rapidly, offering hope to patients and caregivers. Key players in the pharmaceutical industry are actively investing in research and development to bring novel therapies to market, underscoring the potential for transformative interventions in NPC management. Global Niemann-Pick Disease Drug Type C Treatment Market is estimated to be valued at  US$ 45.40  million  in 2024, and is expected to exhibit a  CAG...
Read more